SINAPSE experts from around Scotland have developed ten online modules designed to explain medical imaging. They are freely available and are intended for non-specialists. **Unfortunately these do not currently work in browsers**

Edinburgh Imaging Academy at the University of Edinburgh offers the following online programmes through a virtual learning environment:

Neuroimaging for Research MSc/Dip/Cert

Imaging MSc/Dip/Cert

PET-MR Principles & Applications Cert

Applied Medical Image Analysis Cert

Online Short Courses

PET3D PhD positions in Spain

Two PET imaging PhD positions open in PET3D training network

The EU project PET3D (PET Imaging in Drug Design and Development) is a new Innovative Training Network (ITN) funded (€4M) by the European Commission under the H2020 - MSCA-ITN-2015 programme, and coordinated by Professor Matteo Zanda at the University of Aberdeen.

PET3D is run by a Consortium of Universities and Industries operating in the Pharma sector with the aim to provide excellent, interdisciplinary and cross-sectorial training in Drug Design and Development within an innovative PhD programme for 15 Early Stage Researchers (ESRs).

All of the ESRs recruited by PET3D will be exposed to a variety of highly complementary research environments spanning different therapeutic areas: oncology, cardiovascular, neuroscience and all of the ESRs will spend at least one secondment in a different country and will have the opportunity to attend training events and consortium meetings in all of the 7 countries involved in PET3D.

Applications are now open for two positions at CIC biomaGUNE, San Sebastián, Spain:

PhD fellow: ESR7 'Synthesis and preclinical investigation of boron-enriched gold nanoparticles: a pre-targeting approach to boron neutron capture therapy.' Secondments: 6 months at University of Aberdeen (month 14), 4 months at Imanova, UK (month 35)

Deadline for application: 30 November 2016

PhD fellow: ESR8  'Development and evaluation of bispecific nanoparticles for T cell engagement (Nanobites): a targeted and multimodality approach to cancer therapy.' Secondments: 2 months at Vrije Universiteit Brussel (month 16), 6 months at AstraZeneca, Sweden (month 28)

Deadline for application: 15 December 2016

For details of these positions, go to http://www.abdn.ac.uk/pet3d/recruitment/esr7-esr8-san/